1. Home
  2. BOLD vs PFAI Comparison

BOLD vs PFAI Comparison

Compare BOLD & PFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • PFAI
  • Stock Information
  • Founded
  • BOLD 2018
  • PFAI 2015
  • Country
  • BOLD United States
  • PFAI Canada
  • Employees
  • BOLD N/A
  • PFAI N/A
  • Industry
  • BOLD
  • PFAI Farming/Seeds/Milling
  • Sector
  • BOLD
  • PFAI Consumer Staples
  • Exchange
  • BOLD Nasdaq
  • PFAI Nasdaq
  • Market Cap
  • BOLD 24.4M
  • PFAI 31.4M
  • IPO Year
  • BOLD 2024
  • PFAI 2025
  • Fundamental
  • Price
  • BOLD $1.15
  • PFAI $1.72
  • Analyst Decision
  • BOLD Buy
  • PFAI
  • Analyst Count
  • BOLD 3
  • PFAI 0
  • Target Price
  • BOLD $4.00
  • PFAI N/A
  • AVG Volume (30 Days)
  • BOLD 277.1K
  • PFAI 218.9K
  • Earning Date
  • BOLD 08-11-2025
  • PFAI 01-01-0001
  • Dividend Yield
  • BOLD N/A
  • PFAI N/A
  • EPS Growth
  • BOLD N/A
  • PFAI N/A
  • EPS
  • BOLD N/A
  • PFAI 0.07
  • Revenue
  • BOLD N/A
  • PFAI $2,715,477.00
  • Revenue This Year
  • BOLD N/A
  • PFAI N/A
  • Revenue Next Year
  • BOLD N/A
  • PFAI N/A
  • P/E Ratio
  • BOLD N/A
  • PFAI $23.26
  • Revenue Growth
  • BOLD N/A
  • PFAI 1084.72
  • 52 Week Low
  • BOLD $1.00
  • PFAI $1.55
  • 52 Week High
  • BOLD $4.72
  • PFAI $4.40
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • PFAI N/A
  • Support Level
  • BOLD N/A
  • PFAI N/A
  • Resistance Level
  • BOLD N/A
  • PFAI N/A
  • Average True Range (ATR)
  • BOLD 0.00
  • PFAI 0.00
  • MACD
  • BOLD 0.00
  • PFAI 0.00
  • Stochastic Oscillator
  • BOLD 0.00
  • PFAI 0.00

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About PFAI Pinnacle Food Group Limited Class A Common Shares

Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups and are developing a hydroponic growing system for urban farms.

Share on Social Networks: